New polysubstituted 1,1-pyridylaminocyclopropanamine compounds, a process for their preparation and pharmaceutical compositions containing them

摘要

Polysubstituted 1-amino-1-pyridylaminoalkyl-cyclopropane derivatives of formula (I) are disclosed, wherein the variables are as defined in the specification. These compounds are suitable for the treatment of a condition selected from deficiencies of memory associated with cerebral ageing and with neurodegenerative diseases, and also for the treatment of mood disorders, Tourette's syndrome, attention-deficit hyperactivity syndrome, tobacco withdrawal and pain, and wherein the deficiencies of memory may be particularly associated with Alzheimer's disease, Parkinson's disease, Pick's disease, Korsakoff's disease or frontal lobe and subcortical dementias.